Sinopharm Capital
Sinopharmcapital is a private equity firm that specializes in investments in pharmaceuticals and biotechnology sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sinopharm Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sinopharmcapital is a private equity firm that specializes in investments in pharmaceuticals and biotechnology sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2019 | ArteryFlow | Series A | - |
| 3/2019 | HealthCare Biotech | Series B | - |
| 4/2019 | Suzhou And Science Technology Development | Series A | - |
| 12/2012 | ZC511.com | Angel Round | 481.1k |
| 1/2016 | InventisBio | Series A | 11M |
| 8/2018 | Topsuper | Angel Round | 440.9k |
| 10/2018 | Dr.Yu Pediatrics Clinics | Series A | 2.9M |
| 10/2018 | LinaTech | Seed Round | 2.9M |
| 3/2022 | Artivila Therapeutics | Seed Round | 0 |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 11/2018 | GenFleet Therapeutics | Series A | 17.3M |
| 12/2021 | Sumgen Biotech | Venture Round | - |
| 3/2019 | Dingdang Kuaiyao | Series C | 89M |
| 5/2013 | Anbiping | Series A | 1.6M |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 2/2018 | Ancare Medical | Seed Round | - |
| 12/2021 | Xishan | Series D | 0 |
| 12/2018 | Virogin Biotech | Venture Round | 10M |
| 7/2019 | Synyi | Series C | 36.3M |
| 8/2019 | Baicare | Series B | 9.2M |
| 3/2022 | Metanovas | Seed Round | 10M |
| 11/2021 | Longhui Medical | Series B | 0 |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 9/2021 | Geneus | Series B | - |
| 1/2023 | 4inLook | Venture Round | - |
| 11/2017 | Semma Therapeutics | Series B | 0 |
| 12/2017 | Virtual Incision | Series B | 0 |
| 9/2018 | Eccogene | Series A | 14.6M |
| 12/2018 | Skynor Medical | Series A | 2.9M |
| 11/2020 | Biostar Technologies | Series E | 890M |
| 4/2018 | Eyebright | Series C | - |
| 3/2018 | LYNK Pharmaceuticals | Angel Round | 10M |
| 11/2021 | Shanghai Ouyi Biomedical Technology | Series A | 15.6M |
| 10/2020 | Dingdang Kuaiyao | Series B | 0 |
| 3/2021 | FutureGen | Series B | 46.1M |
| 6/2019 | Novena Global Healthcare Group | Private Equity Round | 0 |
| 3/2020 | GenFleet Therapeutics | Series B | 57.7M |
| 5/2021 | Yikon Genomics | Series D | 38.7M |
| 12/2015 | FHNED | Series A | 1.5M |
| 2/2017 | Abbisko Therapeutics | Series A | 28M |
| 12/2016 | JoyMed Technology | Seed Round | 4.1M |
| 5/2018 | Ansun BioPharma | Series A | 85M |
| 3/2022 | Metanovas | Seed Round | 0 |
| 3/2022 | Artivila Therapeutics | Seed Round | 0 |
| 12/2021 | Xishan | Series D | 0 |
| 12/2021 | Sumgen Biotech | Venture Round | - |
| 11/2021 | Longhui Medical | Series B | 0 |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 11/2021 | Shanghai Ouyi Biomedical Technology | Series A | 0 |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 9/2021 | Geneus | Series B | - |
| 5/2021 | Yikon Genomics | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
